Edit |   |
---|---|
Antigenic Specificity | KIR2DL3 |
Clone | [190IIC311] |
Host Species | Mouse |
Reactive Species | human |
Isotype | IgG2a, k |
Format | Protein G purified |
Size | 0.05 mL, 0.1 mL |
Concentration | 1mg/ml |
Applications | ELISA (EIA), Western Blot (WB), Flow Cytometry (FC/FACS), Immunocytochemistry (ICC), Immunofluorescence (IF) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Reacts with extracellular domain of the KIR2DL3, a member of the Killer cell immunoglobulin-liKe receptor (KIR) family. The KIR family consists of transmembrane glycoproteins of the Ig superfamily expressed on human NK cells and a subset of human T cells which they are involved in recognition of either MHC class I molecules or unKnown ligand on target cells and inhibit cytotoxic activities. |
Immunogen | Immunogen: Recombinant human KIR2DL3 (19-161aa) purified from E. coli |
Other Names | [Killer cell immunoglobulin-like receptor 2DL3; KIR2DL3; CD158B2; KIRCL23; NKAT2; KIR2DL3 (p58 KIR; CD158); MHC class I NK cell receptor; Natural killer-associated transcript 2; NKAT-2; NKAT2a; NKAT2b; p58 natural killer cell receptor clone CL-6; p58 NK receptor; p58.2 MHC class-I-specific NK re; Killer cell immunoglobulin-like receptor 2DL3; Killer cell immunoglobulin-like receptor 2DL3 CD158b; GL183; Killer Cell Immunoglobulin Like Receptor 2DL3; Killer inhibitory receptor CL2 3; KIR023GB; MHC Class I NK Cell Receptor; Natural Killer Associated Transcript 2; p58; p58 Natural Killer Cell Receptor Clone CL6; p58.2 MHC Class I Specific NK Receptor,], [KIR2DL3; KIR2DL3; p58; NKAT; GL183; NKAT2; CD158b; KIR2DL; NKAT2A; NKAT2B; CD158B2; KIR-K7b; KIR-K7c; KIR2DS5; KIRCL23; KIR-023GB; CD158B2; KIRCL23; NKAT2; NKAT-2; p58 NK receptor CL-6] |
Gene, Accession # | [KIR2DL3], Gene ID: 3804, NCBI: NP_055326 |
Catalog # | MBS200001 |
Price | $240, $315 |
Order / More Info | KIR2DL3 Antibody from MYBIOSOURCE INC. |
Product Specific References | Shin JS, et al., (1999) Hybridoma 18:521-527.; Chwae YJ, et al., (2002) J Immunology 169:3726-3735. |